Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 80

1.

Comparison of cross-sectional HIV incidence assay results from dried blood spots and plasma.

Schlusser KE, Pilcher C, Kallas EG, Santos BR, Deeks SG, Facente S, Keating SM, Busch MP, Murphy G, Welte A, Quinn T, Eshleman SH, Laeyendecker O.

PLoS One. 2017 Feb 23;12(2):e0172283. doi: 10.1371/journal.pone.0172283.

2.

Limitations of using the Lorenz curve framework to understand the distribution of population viral load: authors' reply.

Christopoulos KA, Hartogensis W, Glidden DV, Pilcher CD, Gandhi M, Geng EH.

AIDS. 2017 Mar 13;31(5):742-743. doi: 10.1097/QAD.0000000000001407. No abstract available.

PMID:
28225455
3.

The Lorenz curve: a novel method for understanding viral load distribution at the population level.

Christopoulos KA, Hartogensis W, Glidden DV, Pilcher CD, Gandhi M, Geng EH.

AIDS. 2017 Jan 14;31(2):309-310. doi: 10.1097/QAD.0000000000001336.

PMID:
27831945
4.

Performance of the Bio-Rad Geenius HIV1/2 Supplemental Assay in Detecting "Recent" HIV Infection and Calculating Population Incidence.

Keating SM, Kassanjee R, Lebedeva M, Facente SN, MacArthur JC, Grebe E, Murphy G, Welte A, Martin JN, Little S, Price MA, Kallas EG, Busch MP, Pilcher CD.

J Acquir Immune Defic Syndr. 2016 Dec 15;73(5):581-588.

PMID:
27509247
5.

Viral load criteria and threshold optimization to improve HIV incidence assay characteristics.

Kassanjee R, Pilcher CD, Busch MP, Murphy G, Facente SN, Keating SM, Mckinney E, Marson K, Price MA, Martin JN, Little SJ, Hecht FM, Kallas EG, Welte A; Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA)..

AIDS. 2016 Sep 24;30(15):2361-71. doi: 10.1097/QAD.0000000000001209.

PMID:
27454561
6.

The Effect of Same-Day Observed Initiation of Antiretroviral Therapy on HIV Viral Load and Treatment Outcomes in a US Public Health Setting.

Pilcher CD, Ospina-Norvell C, Dasgupta A, Jones D, Hartogensis W, Torres S, Calderon F, Demicco E, Geng E, Gandhi M, Havlir DV, Hatano H.

J Acquir Immune Defic Syndr. 2017 Jan 1;74(1):44-51.

PMID:
27434707
7.

Editorial Commentary: Timing Is Everything: Shortcomings of Current HIV Diagnostics in the Early Treatment Era.

Keating SM, Pilcher CD, Busch MP.

Clin Infect Dis. 2016 Aug 15;63(4):562-4. doi: 10.1093/cid/ciw369. No abstract available.

PMID:
27317798
8.

Gut-Resident Lactobacillus Abundance Associates with IDO1 Inhibition and Th17 Dynamics in SIV-Infected Macaques.

Vujkovic-Cvijin I, Swainson LA, Chu SN, Ortiz AM, Santee CA, Petriello A, Dunham RM, Fadrosh DW, Lin DL, Faruqi AA, Huang Y, Apetrei C, Pandrea I, Hecht FM, Pilcher CD, Klatt NR, Brenchley JM, Lynch SV, McCune JM.

Cell Rep. 2015 Nov 24;13(8):1589-97. doi: 10.1016/j.celrep.2015.10.026.

9.

Efficient Identification of HIV Serodiscordant Couples by Existing HIV Testing Programs in South Brazil.

Pilcher CD, Bisol CA, Paganella MP, Vallabhaneni S, da Motta LR, Kato SK, Sperhacke RD, Kallas EG, Hecht FM, Diaz RS.

PLoS One. 2015 Nov 12;10(11):e0142638. doi: 10.1371/journal.pone.0142638.

10.

Newly Exerted T Cell Pressures on Mutated Epitopes following Transmission Help Maintain Consensus HIV-1 Sequences.

Eriksson EM, Liegler T, Keh CE, Karlsson AC, Holditch SJ, Pilcher CD, Loeb L, Nixon DF, Hecht FM.

PLoS One. 2015 Apr 28;10(4):e0120787. doi: 10.1371/journal.pone.0120787.

11.

Longitudinal Genetic Characterization Reveals That Cell Proliferation Maintains a Persistent HIV Type 1 DNA Pool During Effective HIV Therapy.

von Stockenstrom S, Odevall L, Lee E, Sinclair E, Bacchetti P, Killian M, Epling L, Shao W, Hoh R, Ho T, Faria NR, Lemey P, Albert J, Hunt P, Loeb L, Pilcher C, Poole L, Hatano H, Somsouk M, Douek D, Boritz E, Deeks SG, Hecht FM, Palmer S.

J Infect Dis. 2015 Aug 15;212(4):596-607. doi: 10.1093/infdis/jiv092.

12.

Select host restriction factors are associated with HIV persistence during antiretroviral therapy.

Abdel-Mohsen M, Wang C, Strain MC, Lada SM, Deng X, Cockerham LR, Pilcher CD, Hecht FM, Liegler T, Richman DD, Deeks SG, Pillai SK.

AIDS. 2015 Feb 20;29(4):411-20. doi: 10.1097/QAD.0000000000000572.

13.

High Transmissibility During Early HIV Infection Among Men Who Have Sex With Men-San Francisco, California.

Hollingsworth TD, Pilcher CD, Hecht FM, Deeks SG, Fraser C.

J Infect Dis. 2015 Jun 1;211(11):1757-60. doi: 10.1093/infdis/jiu831.

14.

How can we better identify early HIV infections?

Rosenberg NE, Pilcher CD, Busch MP, Cohen MS.

Curr Opin HIV AIDS. 2015 Jan;10(1):61-8. doi: 10.1097/COH.0000000000000121. Review.

15.

Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository.

Kassanjee R, Pilcher CD, Keating SM, Facente SN, McKinney E, Price MA, Martin JN, Little S, Hecht FM, Kallas EG, Welte A, Busch MP, Murphy G; Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA)..

AIDS. 2014 Oct 23;28(16):2439-49. doi: 10.1097/QAD.0000000000000429.

16.

Dynamic regulation of host restriction factor expression over the course of HIV-1 infection in vivo.

Raposo RA, Abdel-Mohsen M, Deng X, Hecht FM, Pilcher CD, Pillai SK, Nixon DF.

J Virol. 2014 Oct;88(19):11624-9. doi: 10.1128/JVI.01771-14.

17.

Decreased HIV type 1 transcription in CCR5-Δ32 heterozygotes during suppressive antiretroviral therapy.

Wang C, Abdel-Mohsen M, Strain MC, Lada SM, Yukl S, Cockerham LR, Pilcher CD, Hecht FM, Sinclair E, Liegler T, Richman DD, Deeks SG, Pillai SK.

J Infect Dis. 2014 Dec 1;210(11):1838-43. doi: 10.1093/infdis/jiu338.

18.

Programmed death-1 expression on CD4⁺ and CD8⁺ T cells in treated and untreated HIV disease.

Cockerham LR, Jain V, Sinclair E, Glidden DV, Hartogenesis W, Hatano H, Hunt PW, Martin JN, Pilcher CD, Sekaly R, McCune JM, Hecht FM, Deeks SG.

AIDS. 2014 Jul 31;28(12):1749-58. doi: 10.1097/QAD.0000000000000314.

19.

Direct visualization of HIV-enhancing endogenous amyloid fibrils in human semen.

Usmani SM, Zirafi O, Müller JA, Sandi-Monroy NL, Yadav JK, Meier C, Weil T, Roan NR, Greene WC, Walther P, Nilsson KP, Hammarström P, Wetzel R, Pilcher CD, Gagsteiger F, Fändrich M, Kirchhoff F, Münch J.

Nat Commun. 2014 Apr 1;5:3508. doi: 10.1038/ncomms4508.

20.

Trans-activation, post-transcriptional maturation, and induction of antibodies to HERV-K (HML-2) envelope transmembrane protein in HIV-1 infection.

Michaud HA, de Mulder M, SenGupta D, Deeks SG, Martin JN, Pilcher CD, Hecht FM, Sacha JB, Nixon DF.

Retrovirology. 2014 Jan 28;11:10. doi: 10.1186/1742-4690-11-10.

Supplemental Content

Loading ...
Support Center